 | Up a level |
Hentschel, Michael; Rottenburger, Christof; Boedeker, Carsten C; Neumann, Hartmut P H; Brink, Ingo (2012). Is there an optimal scan time for 6-[F-18]fluoro-L-DOPA PET in pheochromocytomas and paragangliomas? Clinical nuclear medicine, 37(2), e24-9. Philadelphia, Pa.: Lippincott Williams & Wilkins 10.1097/RLU.0b013e318238f550
Wild, Damian; Fani, Melpomeni; Behe, Martin; Brink, Ingo; Rivier, Jean E F; Reubi, Jean-Claude; Maecke, Helmut R; Weber, Wolfgang A (2011). First clinical evidence that imaging with somatostatin receptor antagonists is feasible. Journal of nuclear medicine, 52(9), pp. 1412-7. New York, N.Y.: Society of Nuclear Medicine 10.2967/jnumed.111.088922
Rottenburger, Christof; Hentschel, Michael; Kelly, Thomas; Trippel, Michael; Brink, Ingo; Reithmeier, Thomas; Meyer, Philipp Tobias; Nikkhah, Guido (2011). Comparison of C-11 methionine and C-11 choline for PET imaging of brain metastases: a prospective pilot study. Clinical nuclear medicine, 36(8), pp. 639-42. Philadelphia, Pa.: Lippincott Williams & Wilkins 10.1097/RLU.0b013e3182175840
